Conference Call Preliminary FY 2022 Results
Joachim Kreuzburg, Rainer Lehmann
Sartorius | Sartorius Stedim Biotech | January 26, 2023
Overview
- Sales revenue +15%cc to €4.2bn: both divisions show double-digit growth
- Underlying EBITDA +20% to €1.4bn; margin of 33.8% close to high prior-year level
- Outlook 2023: low single-digit sales growth, high single-digit excluding Covid business; underlying EBITDA margin around prior-year level
- Ambition 2025: fundamentally confirmed; sales revenue target increased for inflation to ~€5.5bn, margin target unchanged
- Uncertainties remain high due to global geopolitical and economic situation
2
Agenda
Sartorius Group Preliminary FY 2022 results |
FY 2023 outlook | Ambition 2025
Sartorius Stedim Biotech Group Preliminary FY 2022 results |
FY 2023 outlook | Ambition 2025
Questions & Answers
3
Sartorius Group
Strong double-digit sales growth, margin close to high prior-year level
Sartorius Group | FY 2021 | FY 2022 | in % | in % cc1 |
in millions of € unless otherwise specified | ||||
Sales revenue | 3,449 | 4,175 | +21.0 | +15.0 |
Order intake | 4,268 | 4,007 | -6.1 | -10.1 |
Underlying EBITDA2 | 1,175 | 1,410 | +20.0 | |
Underlying EBITDA2 margin in % | 34.1 | 33.8 | -0.3pp | |
Underlying EPS3 (ord.) in € | 8.08 | 9.57 | +18.4 | |
Underlying EPS3 (pref.) in € | 8.09 | 9.58 | +18.4 |
- Strong organic sales growth; acquisitions contribute close to 2pp; Covid-related sales significantly down to ~€220m
- OI reflects normalizing demand and substantially lower Covid business; excl. Covid business OI growth is slightly positive
- Strong underlying EBITDA margin close to prior year despite expected catch-up of costs and slight FX-related headwinds
1 Constant currencies 2 Underlying = excluding extraordinary items 3 Underlying EPS = based on net profit after non-controlling interest; adjusted for extraordinary items as well as amortization and based on a normalized financial result and normalized tax rate
4
Sartorius Group
High growth across all geographies; Americas expand the fastest
Americas
- in millions
+21.4% |
1,544 |
1,141 |
FY 2021 FY 2022
EMEA
- in millions
+9.0% | |
1,411 | 1,551 |
FY 2021 FY 2022
Asia|Pacific
- in millions
+16.2%
1,080 |
897 |
FY 2021 FY 2022
Sales by Region
in %
EMEA | Americas |
~ 37% | ~ 37% |
€4,175m
Asia|Pacific
~ 26%
- The Americas contribute most to strong sales revenue growth
- Good growth in EMEA despite tough comparables; strong reduction of business in Russia
- Partial lockdowns in China with no significant impact on growth in Asia|Pacific
Acc. to customers' location; growth in constant currencies
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Sartorius AG published this content on 26 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 January 2023 13:52:04 UTC.